Elevated expression of PSMA2 has been correlated with poor survival in breast cancer patients [13] and it enhances proliferation, migration, and invasion in colorectal cancer and glioma [14, 15] while also being involved in immune and cellular stress responses in human lung cancer, ovarian cancer, leukemia and colorectal cancer [14, 16–18]. Here, PSMA2 is linked to glioma.